Brokerages Anticipate Transcat, Inc. (TRNS) to Post $0.26 Earnings Per Share
Shares of Transcat, Inc. (NASDAQ:TRNS) have been assigned a consensus broker rating score of 1.33 (Strong Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating and two have assigned a strong buy rating to the company.
Analysts have set a one year consensus price objective of $27.67 for the company and are expecting that the company will post $0.26 earnings per share for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 63 out of 257 based on the ratings given to its competitors.
TRNS has been the subject of several recent analyst reports. Zacks Investment Research raised shares of Transcat from a “hold” rating to a “buy” rating and set a $25.00 price objective for the company in a research note on Saturday, July 28th. Singular Research lifted their price objective on shares of Transcat from $25.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, August 21st.
Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Wednesday, October 24th. The scientific and technical instruments company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. The company had revenue of $38.88 million during the quarter, compared to analyst estimates of $38.00 million. Transcat had a net margin of 4.54% and a return on equity of 12.45%. Equities research analysts anticipate that Transcat will post 1 EPS for the current year.
In other Transcat news, Director John T. Smith sold 3,000 shares of Transcat stock in a transaction on Wednesday, October 31st. The shares were sold at an average price of $10.30, for a total transaction of $30,900.00. Following the completion of the transaction, the director now directly owns 42,166 shares of the company’s stock, valued at $434,309.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold 10,639 shares of company stock valued at $109,307 over the last ninety days. 8.80% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its stake in Transcat by 2.8% during the first quarter. Dimensional Fund Advisors LP now owns 316,063 shares of the scientific and technical instruments company’s stock worth $4,946,000 after buying an additional 8,621 shares during the period. UBS Group AG boosted its stake in shares of Transcat by 62.9% during the first quarter. UBS Group AG now owns 66,465 shares of the scientific and technical instruments company’s stock valued at $1,040,000 after purchasing an additional 25,664 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Transcat by 52.4% during the second quarter. Renaissance Technologies LLC now owns 74,981 shares of the scientific and technical instruments company’s stock valued at $1,417,000 after purchasing an additional 25,784 shares during the period. Acadian Asset Management LLC boosted its stake in shares of Transcat by 491.7% during the second quarter. Acadian Asset Management LLC now owns 18,485 shares of the scientific and technical instruments company’s stock valued at $350,000 after purchasing an additional 15,361 shares during the period. Finally, Spark Investment Management LLC purchased a new stake in shares of Transcat during the second quarter valued at $219,000. 55.17% of the stock is owned by institutional investors.
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Further Reading: Why do company’s buyback their stock?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.